Navigation Links
NCI renews Mayo Clinic Cancer Center support grant, extends comprehensive status

ROCHESTER, Minn. -- The Mayo Clinic Cancer Center (MCCC) received an additional five years of National Cancer Institute (NCI) funding and re-designation as a comprehensive cancer center, according to Robert Diasio, M.D., the center's director. Mayo Clinic has the only NCI-designated comprehensive cancer center conducting research at three distinct locations across the United States.

The NCI Cancer Center Support Grant award to MCCC totals more than $28 million over five years for infrastructure and administrative support for cancer center researchers across Mayo's three sites in Minnesota, Florida and Arizona.

"The NCI renewal of Mayo's Cancer Center Support Grant ensures the continuity of research programs that contribute to improved medical options for cancer patients," Dr. Diasio says. "This NCI grant is key in enabling Mayo Clinic to continue delivering outstanding care for its cancer patients."

The MCCC is headquartered in Rochester, Minn., with research campuses in Scottsdale, Ariz., and Jacksonville, Fla. With NCI approval in 2003, MCCC incorporated its cancer research activity at its Minnesota, Florida and Arizona sites into a single, integrated institution.

"The NCI recognized the Mayo Clinic Cancer Center for excellence in basic and clinical research, and for our contributions to cancer prevention, control and population sciences," Dr. Diasio says. "This award enables Mayo cancer researchers on all three of our campuses to build upon knowledge that leads to changes in medical practice which means improved treatment opportunities for our patients."

Within its scope as a NCI-designated comprehensive cancer center, the MCCC designs and develops translational clinical studies that arise from collaborations between scientists and physicians.

The 450 scientists and physicians of the MCCC faculty across all three sites are organized into programs that focus on 12 key cancer research themes. They include Women's Cancers, Neuro-Oncology, Hematologic (bloodborne) Malignancies, Gene and Virus Therapy, Developmental Therapeutics, Genetic Epidemiology and Risk Assessment, Immunology and Immunotherapy, Gastrointestinal Cancers, Prostate Cancer, Cell Biology, Cancer Imaging, and Cancer Prevention and Control.


Contact: Karl Oestreich
Mayo Clinic

Related medicine news :

1. Cardinal Health Renews Distribution Agreement With CVS Caremark
2. The European Association for the Study of the Liver renews publishing partnership with Elsevier
3. Nuvilex Renews MedX Master Distribution Agreement and Implements New Pricing for Talsyn Scar Cream
4. DC Government Renews Certified Business Enterprise Classification to Language Interpretation and Translation Firm
5. New York Merchants Protective Co. Renews CSAA Five Diamond Certification
6. Specialists On Call Renews Joint Commission Accreditation
7. New book series renews call for ban on gambling
8. Doctor Diabetic Supply, Inc. Renews its ACHC Accreditation
9. American TeleCare, Inc. (ATI) Renews Agreements for its Telehealth Solutions with the Veterans Health Administration
10. Rochester Medical Renews Share Repurchase Activity
11. Clarient Renews and Expands Mezzanine Credit Facility With Safeguard
Post Your Comments:
(Date:11/29/2015)... ... November 29, 2015 , ... Khanna Vision Institute based in Los Angeles, announced ... November 25th 2015. Peer Certification by the Board is done so the public knows ... is first obtained after the completion of three years of training or Residency in ...
(Date:11/29/2015)... ... November 29, 2015 , ... ProStatic Analog Distortion from Pixel ... specially for Final Cut Pro X. FCPX users can now apply ... controls. Destoying and creating chaotic distortion is now quick and simple, putting film ...
(Date:11/28/2015)... (PRWEB) , ... November 28, 2015 , ... ... exchange technology and teleradiology services, has added Chris Hafey and Claude Hooton to ... at the Radiological Society of North America (RSNA) 2015 Annual Meeting and continues ...
(Date:11/28/2015)... ... November 28, 2015 , ... Beginning November 30th at 6:00 a.m. EST until 11:59 p.m. ... , With possible savings of up to 20% off orders $80 or more to free ... website every few hours. , As a competitive e-commerce website for skin care and cosmetic ...
(Date:11/27/2015)... Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... conversation at the recent 2015 American Dental Association meeting in Washington D.C. revolved around ... help protect a patient’s overall health. The talk stressed the link between periodontal disease ...
Breaking Medicine News(10 mins):
(Date:11/29/2015)... Nov. 29, 2015 CIVCO Medical Solutions ... at the Radiological Society of North ... Chicago November 29 – December 4, ... to offer customers unrivaled versatility, enhanced user experience ... --> ...
(Date:11/27/2015)... 27, 2015 Une nouvelle ... au Bremachlorin contre le cancer avancé.    ... combiner l,immunothérapie au traitement photodynamique au Bremachlorin contre ... Une nouvelle approche consistant à combiner l,immunothérapie ... avancé.    Clinical Cancer Research ...
(Date:11/27/2015)... , Niederlande, November 27, 2015 ... fotodynamischer Bremachlorin-Therapie bei fortgeschrittenem Krebs.   --> ... Bremachlorin-Therapie bei fortgeschrittenem Krebs.   --> ... Bremachlorin-Therapie bei fortgeschrittenem Krebs.   Clinical ... --> Clinical Cancer Research vom ...
Breaking Medicine Technology: